Brian Nowosielski

Andrea Sikora, PharmD, MSCR, FCCM, FCCP, BCCCP, led a 21-member panel on critical care pharmacists and joined us to discuss how guideline updates may impact the greater pharmacy industry.

In hospitalized patients with obesity, researchers conduct a study detailing how electronic clinical support helps participants optimize their treatment regimens.

Along with additional bills to further bolster PBM reform, the organizations are aiming to pass the PBM Reform Act for improved medication costs and community pharmacy sustainability.

Andrea Sikora, PharmD, MSCR, FCCM, FCCP, BCCCP, chair of the committee presenting new guidelines, discussed her role in bolstering pharmacists’ support in the ICU.

Among individuals with both diabetes and HIV, researchers determine patients’ adherence to comprehensive diabetes care interventions.

The Medicare Drug Price Negotiation Program is anticipated to cause multiple issues for pharmacy owners and their cashflow sustainability.

Medtronic’s diabetes management technology reached 2 milestones upon FDA approval, allowing integration of continuous glucose monitoring for patients with type 1 and type 2 diabetes.

After experiencing tragedy in his personal life, Bil Schmidtknecht was led to join the community of independent pharmacists and industry advocates calling for PBM reform across both aisles.

Exploring the influences of pneumococcal disease mortality and events of the COVID-19 pandemic, researchers investigate changes in US pneumococcus survival rates since 2020.

With hypertension commonly leading to increased risk of mortality, researchers aimed to understand the hypertensive survival rates of patients with diabetes over a 20-year period.

Regardless of which stakeholders are involved, a collective, team effort is necessary to achieve state- and federal-level PBM reform.

Using results from the Rx for Change program in Pittsburgh, Pennsylvania, researchers explored an integrative approach to cardiometabolic disease management among Black patients.

Detailing the public health impact of an Rx-to-OTC switch, researchers explored the reclassification of triptan medications in Germany.

From the perspective of someone directly impacted by PBM practices, Bil Schmidtknecht shares his insights into the ways PBMs affect patients’ access to medications.

After sharing his son’s tragic story, Bil Schmidtknecht discusses the common ways the Big 3 PBMs operate and how smaller organizations are on the rise, becoming unlikely competitors.

Researchers explored the association of body mass index and all-cause mortality rates among older adults undergoing major elective surgery.

Bil Schmidtknecht joined Drug Topics to share his son’s tragic story and how it motivated him to join the greater fight in putting the lives of patients at the forefront of health care.

Among older adults with Medicare, researchers investigated national influenza vaccination patterns by race, education level, and rurality.

Researchers explored the impact of PCV10 on the distribution of invasive pneumococcal disease serotypes among patients in Lithuania.

Addressing the impacts on patients and the overall pharmacy market, Joey Mattingly, PharmD, MBA, PhD, discusses trends in pharmacies opening and closing across the country.

Through considerations regarding cost, scalability, safety, and regulations, researchers provided an end-to-end perspective on microneedle-based vaccine strategies.

In part 3 of our interview with Joey Mattingly, PharmD, MBA, PhD, he discusses potential government policies for reducing pharmacy closures.

The event will focus on patient access and education in pharmacy practice, featuring industry leaders providing actionable strategies and real-world solutions for independent pharmacies.

Among participants in the CATCH trial, researchers explored the relationship between HPV vaccination and incidence of infection.

Joey Mattingly, PharmD, MBA, PhD, discussed the reasons why pharmacies may open or close and where exactly PBMs fall in line amid common pharmacy turnover trends.

Researchers explored the real-world dose titration, adherence rates, and effectiveness of glucagon-like peptide-1 medications among patients in a multidisciplinary obesity clinic.

Expert pharmacy business researcher Joey Mattingly, PharmD, MBA, PhD, joined Drug Topics to discuss recent trends in pharmacy churn and how it directly impacts patients.

In association with patients’ race, ethnicity, and social determinants of health, researchers explored the off-label prescribing of GLP-1s approved for type 2 diabetes.

To better understand its potential role in the pharmacy profession, researchers explore artificial intelligence and the ways pharmacists are aware of its growing implementation.

In an exploration of provider reporting and pharmacovigilance, researchers assessed community pharmacists’ knowledge, attitudes, and practices regarding adverse drug reactions.